Riskpilot← Back to searchSign inGet full accessResursläkare Skåne AB
ABActiveOrg 5592611668Filippagatan 34Hospital activities · NACE 8610Est. 20201 employees
Revenue 2025
SEK 457K
-23% vs 2024
EBITDA margin
42.4%
-32% vs 2024
Equity ratio
70.4%
Financial strength
Net profit 2025
SEK 325K
+15% vs 2024
| Revenue | SEK 457K | -23% |
| EBITDA | SEK 194K | -32% |
| Net profit | SEK 325K | +15% |
| Total assets | SEK 661K | -4% |
| Equity | SEK 466K | +37% |
| Employees | 1 | — |
Legal name
Resursläkare Skåne AB
Org number
5592611668
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
29 juni 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska erbjuda specialisttjänster till vården. Tjänsterna innefattar framför allt arbete som specialistläkare inom både sluten- och öppenvården.
Address
Filippagatan 34
Email
arkinderakhshin@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 218 | 616 | 455 | 591 | 457 |
| Staff expenses | — | — | −63 | −39 | −51 |
| EBITDA | 982 | 284 | 188 | 284 | 194 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 982 | 284 | 188 | 284 | 194 |
| Net financials | 63 | −350 | −115 | 58 | 102 |
| Profit before tax | 674 | 109 | 74 | 342 | 386 |
| Tax | −158 | −59 | −40 | −60 | −61 |
| Net profit | 516 | 50 | 33 | 282 | 325 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 209 | 872 | 538 | 687 | 661 |
| Equity | 541 | 408 | 254 | 340 | 466 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 422 | 219 | 39 | 101 | 41 |
| Total debt | 422 | 219 | 39 | 101 | 41 |
EBITDA margin
42.4%
This company
15.8%
Market median
+168% vs market
20212025
Equity ratio
70.4%
This company
38.2%
Market median
+84% vs market
20212025
Return on equity
69.9%
This company
18.4%
Market median
+280% vs market
20212025
Net profit margin
71.1%
This company
8.1%
Market median
+778% vs market
20212025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Resursläkare Skåne AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hami Arkin Derakhshin | Board of Directors | 0 companies |
| Parisa Baradaran | Board of Directors | 0 companies |